Add like
Add dislike
Add to saved papers

[Analysis of risk factors for prognosis of patients with acute paraquat intoxication].

OBJECTIVE: To explore the risk factors influencing the prognosis by analyzing clinical data of patients with acute paraquat intoxication, and to assess the prognostic values of acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score, and Acute Kidney Injury Network (AKIN) stage.

METHODS: The clinical data of patients with acute paraquat intoxication admitted into the First People's Hospital of Xianyang City during October 2005 to May 2015 were retrospectively analyzed. The patients were divided into death group and survival group according to 28-day outcome after poisoning. The gender, age, body weight index, toxin dose, time elapsed from poisoning to gastric lavage, time elapsed from poisoning to hemoperfusion (HP), times of HP treatment, white blood cell count (WBC), alanine aminotransferase (ALT), aspartate transaminase (AST), total bilirubin (TBil), serum creatinine (SCr), blood urea nitrogen (BUN), creatine kinase (CK) were determined at admission. Arterial partial pressure of oxygen (PaO₂), arterial partial pressure of carbon dioxide (PaCO₂), arterial lactate (Lac), and APACHE II score, SOFA score and AKIN stage were recorded and compared between two groups. The receiver operating characteristic (ROC) curve was plotted for APACHE II score, SOFA score and AKIN stage to analyze the prognostic value for patients with acute paraquat intoxication.

RESULTS: There were 118 cases in total, with 64 survivors and 54 deaths in 28 days, and the fatality rate was 45.76%. Compared with survival group, the toxic dose (mL: 66.29 ± 27.40 vs. 29.16 ± 19.40), time elapsed from poisoning to gastric lavage (minutes: 60.37 26.68 vs. 41.17 ± 14.82), WBC count ( X 10⁹/L: 16.86 ± 2.77 vs. 10.25 ± 2.60), ALT (U/L: 53.94 ± 10.85 vs. 36.40 ± 9.21), SCr (μmol/L: 159.69 ± 42.85 vs. 81.73 ± 34.40) at admission as well as Lac (mmol/L: 3.06 ± 1.33 vs. 1.71 ± 0.88), APACHE II score (6.46 ± 2.38 vs. 3.31 ± 1.51), SOFA score (3.31 ± 1.06 vs. 2.21 ± 0.76) 48 hours after admission were significantly higher in the death group (all P < 0.01). PaO₂ and PaCO₂ 48 hours after admission were significantly lower in death group than those in the survival group [PaO₂ (mmHg, 1 mmHg = 0.133 kPa): 64.07 ± 13.04 vs. 75.40 ± 13.27, PaCO₂ (mmHg): 26.20 ± 8.89 vs. 31.25 ± 6.29, both P < 0.01]. There were 18, 15, 11 and 10 patients in AKIN 0, 1, 2, 3 stage 48 hours after admission respectively in death group, and 38, 15, 7, 4 in survival group. The difference between two groups was statistically significant (P < 0.01). There were no statistically significant differences in gender, age, body mass index, time elapsed from poisoning to HP, levels of HP, and AST, TBil, BUN and CK at admission between the two groups. At 48 hours after admission, the area under the ROC curve (AUC) of APACHE II score predicting the prognosis of patients with acute paraquat poisoning was 0.875 [95% confidence interval (95%CI) = 0.814-0.935, P = 0.000]. When the cut-off point of APACHE II score was 4, the sensitivity and specificity were 79.6% and 79.7%, and the best Youden index was 0.593. The AUC of SOFA score was 0.776 (95% CI = 0.692-0.859, P = 0.000). When the cut-off point of FOFA score was 3, the sensitivity was 72.2%, the specificity 67.2%, and the best Youden index 0.394. The AKIN stage of ROC curve had an area of 0.656 (95% CI = 0.556-0.755, P = 0.004). When the cut-off point of AKIN stage was 1, the sensitivity was 66.7%, the specificity was 59.4%, and the best Youden index was 0.261.

CONCLUSIONS: Amount of the poison, time elapsed from poisoning to gastric lavage, and WBC, ALT, SCr at admission as well as PaO₂, PaCO₂ and Lac 48 hours after admission are the risk factors for prediction of the prognosis of acute paraquat intoxication. APACHE II score, SOFA score and AKIN stage can be used to assess the prognosis of acute paraquat poisoning, and APACHE II score is better than SOFA score and AKIN stage.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app